12:00 AM
 | 
Mar 04, 2013
 |  BC Week In Review  |  Company News  |  Other News

Roche pharmaceuticals news

Roche said it will work with an independent body to grant third-party researchers access to anonymized patient-level clinical trial data starting this year. The pharma said it will also support the release by regulatory authorities of full clinical trial reports along with summaries and safety updates for all of its drugs that are approved in the EU...

Read the full 264 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >